The dollar value of these insider sales is negligible relative to EW's market cap. No actionable signal, treat as routine portfolio management. Monitor for any larger insider sales or a broader selling pattern in coming weeks.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 1 $88.17entry
- T+1 · 6mo ago −0.96%α −1.11% · $87.32
- T+5 · 5mo ago −2.50%α +0.25% · $85.96
- T+20 · 5mo ago +3.42%α +5.73% · $91.18
- T+60 · 3mo ago +3.07%α +2.09% · $90.87
Price Chart
How similar events traded
Executive Summary
Three Edwards Lifesciences insiders sold a total of ~$2.18M in open-market sales over a 7-day window, led by the CVP of Strategy/Corporate Development ($2.0M). The cluster is dominated by a single large sale from a senior corporate development officer, which may signal a bearish view on near-term prospects or simply reflect routine portfolio diversification. At 0.004% of market cap, the dollar value is trivial relative to the company's $49.5B market cap, making this a low-impact event.
Key Financial Metrics
Key Facts
- Three insiders sold a total of ~$2.18M in open-market sales between May 22-29, 2026.
- The largest sale was by Donald E. Bobo Jr. (CVP, Strategy/Corp Development): 23,145 shares at $86.42 for ~$2.0M.
- Daveen Chopra (CVP, TMTT & Surgical) sold 1,500 shares at $84.60 for ~$127K.
- Andrew M. Dahl (SVP, Corporate Controller) sold 568 shares at $86.08 for ~$49K.
- Total insider sales represent ~0.004% of EW's $49.5B market cap, well below the 0.1% materiality threshold.
- No insider purchases were reported in the cluster window.
Financial Impact
Total insider sales of ~$2.18M, or 0.004% of market cap, immaterial.
Risk Factors
- If additional insiders begin selling in larger volumes, it could signal deteriorating confidence.
- The $2.0M sale by the corporate development officer may be tied to a 10b5-1 plan or personal liquidity needs, not necessarily bearish.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-EW-1780087492742 |
Track record
27 reports on EW
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +4.94% at T+5 after the Nov 4, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 3/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $100.82 to $105.80 Now $107.11 +6.24% ▲ +4.94% +1.65% vs SPY
- Oct 29, 202618d ago Institutional Cluster Neutral 3/10 Entry $94.44 to $100.82 Now $107.11 +13.42% ▲ +6.76% +11.48% vs SPY
- Aug 31, 202611w ago Insider Cluster Neutral 2/10 Entry $90.74 to $86.18 Now $107.11 +18.04% ▼ −5.03% −5.11% vs SPY
- Aug 28, 202611w ago Insider Cluster Neutral 2/10 Entry $90.75 to $86.72 Now $107.11 +18.03% ▼ −4.44% −4.30% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers